Literature DB >> 30353312

Differences in Right Ventricular Physiologic Response to Chronic Volume Load in Patients with Repaired Pulmonary Atresia Intact Ventricular Septum/Critical Pulmonary Stenosis Versus Tetralogy of Fallot.

Andrew L Cheng1, Abraham M Kaslow2, Jay D Pruetz3, Jimmy C Lu4, John C Wood3,2, Jon A Detterich3,2.   

Abstract

BACKGROUND: Patients with pulmonary atresia with intact ventricular septum and critical pulmonary stenosis (PAIVS/CPS) have wide variation in right ventricle (RV) size, systolic function, and diastolic function at birth. Establishment of antegrade pulmonary blood flow creates the potential for RV dilation from chronic pulmonary insufficiency. Future surgical decisions are based on RV size and function, largely supported by longitudinal studies of patients with Tetralogy of Fallot (TOF). Given potential differences in RV physiology and lack of similar data in PAIVS/CPS, the objective of this study was to determine differences in RV size, systolic function, and diastolic function between patients with PAIVS/CPS versus TOF.
METHODS: We retrospectively collected cardiovascular magnetic resonance (CMR) data in 27 patients with PAIVS/CPS (ages 13.3 ± 8.8 years) and 78 with TOF (11.4 ± 5.4 years). RV volumes, ejection fraction (EF), regurgitant fraction, end-diastolic forward flow across the pulmonary valve, and right atrial cross-sectional area were calculated.
RESULTS: There was no difference between the groups in RV end-diastolic volume (RVEDVi), RVEF, or pulmonary regurgitation. RVEF tended to decrease in TOF when RVEDVi exceeded 164 ml/m2. In PAIVS/CPS, RVEDVi less frequently reached 164 ml/m2 and was not associated with RVEF. There was worse RV diastolic dysfunction in PAIVS/CPS, with 1.5 times larger right atrial area and two times higher pulmonary end-diastolic forward flow (p < 0.0001).
CONCLUSIONS: Patients with PAIVS/CPS have similar RV size, systolic function, and pulmonary regurgitation as TOF. However, impaired RV diastolic function may limit extremes of RV dilatation and impact long-term management of PAIVS/CPS.

Entities:  

Keywords:  Cardiovascular magnetic resonance; Echocardiography; Pulmonary atresia; Pulmonary stenosis; Tetralogy of Fallot

Mesh:

Year:  2018        PMID: 30353312     DOI: 10.1007/s00246-018-2009-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  30 in total

1.  Staged biventricular repair of pulmonary atresia or stenosis with intact ventricular septum.

Authors:  S Sano; K Ishino; M Kawada; E Fujisawa; M Kamada; S Ohtsuki
Journal:  Ann Thorac Surg       Date:  2000-11       Impact factor: 4.330

2.  Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging.

Authors:  Tal Geva; Bryan M Sandweiss; Kimberlee Gauvreau; James E Lock; Andrew J Powell
Journal:  J Am Coll Cardiol       Date:  2004-03-17       Impact factor: 24.094

3.  Improved results with selective management in pulmonary atresia with intact ventricular septum.

Authors:  M Jahangiri; D Zurakowski; D Bichell; J E Mayer; P J del Nido; R A Jonas
Journal:  J Thorac Cardiovasc Surg       Date:  1999-12       Impact factor: 5.209

4.  Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography.

Authors:  Wyman W Lai; Tal Geva; Girish S Shirali; Peter C Frommelt; Richard A Humes; Michael M Brook; Ricardo H Pignatelli; Jack Rychik
Journal:  J Am Soc Echocardiogr       Date:  2006-12       Impact factor: 5.251

5.  Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair.

Authors:  A L Knauth; K Gauvreau; A J Powell; M J Landzberg; E P Walsh; J E Lock; P J del Nido; T Geva
Journal:  Heart       Date:  2006-11-29       Impact factor: 5.994

6.  Pulmonary atresia with intact ventricular septum percutaneous radiofrequency-assisted valvotomy and balloon dilation versus surgical valvotomy and Blalock Taussig shunt.

Authors:  M Alwi; K Geetha; A A Bilkis; M K Lim; S Hasri; A L Haifa; A Sallehudin; R Zambahari
Journal:  J Am Coll Cardiol       Date:  2000-02       Impact factor: 24.094

7.  Right ventricular growth in a case of pulmonic stenosis with intact ventricular septum and hypoplastic right ventricle.

Authors:  P S Rao; J Liebman; G Borkat
Journal:  Circulation       Date:  1976-02       Impact factor: 29.690

8.  Right atrial volume index in chronic systolic heart failure and prognosis.

Authors:  John A Sallach; W H Wilson Tang; Allen G Borowski; Wilson Tong; Tama Porter; Maureen G Martin; Susan E Jasper; Kevin Shrestha; Richard W Troughton; Allan L Klein
Journal:  JACC Cardiovasc Imaging       Date:  2009-05

9.  Determinants of mortality and type of repair in neonates with pulmonary atresia and intact ventricular septum.

Authors:  David A Ashburn; Eugene H Blackstone; Winfield J Wells; Richard A Jonas; Frank A Pigula; Peter B Manning; Gary K Lofland; William G Williams; Brian W McCrindle
Journal:  J Thorac Cardiovasc Surg       Date:  2004-04       Impact factor: 5.209

10.  Restrictive right ventricular physiology: its presence and symptomatic contribution in patients with pulmonary valvular stenosis.

Authors:  Yat-Yin Lam; Mehmet G Kaya; Omer Goktekin; Michael A Gatzoulis; Wei Li; Michael Y Henein
Journal:  J Am Coll Cardiol       Date:  2007-09-24       Impact factor: 24.094

View more
  2 in total

Review 1.  End-Diastolic Forward Flow and Restrictive Physiology in Repaired Tetralogy of Fallot: A Systematic Review and Meta-Analysis.

Authors:  Jef Van den Eynde; Emilie Derdeyn; Art Schuermans; Pushpa Shivaram; Werner Budts; David A Danford; Shelby Kutty
Journal:  J Am Heart Assoc       Date:  2022-03-18       Impact factor: 6.106

2.  Elabela: A Novel Biomarker for Right Ventricular Pressure Overload in Children With Pulmonary Stenosis or Pulmonary Atresia With Intact Ventricular Septum.

Authors:  Jian Wang; Yue Zhou; Qingjie Wang; Bowen Du; Yurong Wu; Qian Chen; Xi Zhang; Yanan Lu; Sun Chen; Kun Sun
Journal:  Front Cardiovasc Med       Date:  2020-11-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.